Contact Information
Company Information
Company
Treadwell Therapeutics, Inc.
Total Funding
118000000.0
Technologies
Outlook
WP Engine
Greenhouse.io
Vimeo
BugHerd
Mobile Friendly
Gravity Forms
Google Tag Manager
reCAPTCHA
WordPress.org
Remote
Keywords
biotechnology research
oncology
drug discovery
clinical stage
therapeutic intervention
novel targets
biologics
small molecule
t-cell receptor therapy
pipeline
cancer treatment
research & development
clinical trials
first-in-class
immune-oncology
plk4 inhibitor
ttk inhibitor
hpk1 inhibitor
biologic programs
targeted therapy
acute myeloid leukemia
er+ breast cancer
triple negative breast cancer
solid tumors
liquid tumors
genomic instability
cancer cell proliferation
cancer patient
clinical development
expanded access
compassionate use
cancer therapies
dysregulated pathways
targeting mitosis
functional genomics
rnai screens
tcr identification
high-throughput screening
cancer genomics
tumor profiling
research collaborators
investigational drugs
biotechnology
biopharma
clinical candidates
drug development
therapeutic modalities
hospital & health care
health care
health
wellness & fitness
Get Full Contact Details
Subscribe to reveal email addresses and export contacts.
View Plans